Abstract: The present invention relates to polymorphic forms of Bictegravir potassium of Formula II, process for their preparation and pharmaceutical composition comprising it.

Abstract: The present invention relates to polymorphic forms of Tafamidis of Formula I and process for their preparation and pharmaceutical composition comprising it.

Abstract: A process for preparing a sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl) carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1?,2?:4,5] pyrazino[2,1-b][1,3]oxazepin-8-olate of Formula 1 and its polymorphic form thereof.

Abstract: Embodiments of the present disclosure provide control systems and methods to reduce wastage of energy associated with fuel cell systems. The method includes transmitting DC power from a plurality of fuel cells of a set of power modules to a centralized DC bus through a first set of DC-DC converters. The method includes operating a second set of DC-DC converters to provide an output DC power by boosting a voltage level of the DC power from the centralized DC bus and further operating a first set of DC-AC inverters to convert the DC power from the second set of DC-DC converters to AC power. The method includes transmitting the AC power from the first set of DC-AC inverters to a grid. The AC power is transmitted to the grid at substantially unity power factor due to combined effect of switching modulation and MPPT of the first set of DC-AC inverters.

Abstract: The present invention relates to polymorphic forms of Bictegravir potassium of Formula II, process for their preparation and pharmaceutical composition comprising it.

Abstract: A process for preparing a sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl) carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1?,2?:4,5] pyrazino[2,1-b][1,3]oxazepin-8-olate of Formula 1 and its polymorphic form thereof.

Abstract: The present invention relates to process for the preparation of sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl )carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1?,2?:4,5] pyrazino[2,1-b] [1,3] oxazepin-8-olate of Formula-I and its polymorphic form thereof.

Abstract: The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.

Abstract: A fuel cell device includes at least one fuel cell column containing first and second fuel cell stacks, a fuel manifold located between the first and second fuel cell stacks and configured to provide fuel to the first and second fuel cell stacks, and a dielectric material located to electrically isolate the first and second fuel cell stacks from the fuel manifold.

Abstract: The present invention relates to process for the preparation of sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl )carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1?,2?:4,5] pyrazino[2,1-b] [1,3] oxazepin-8-olate of Formula-I and its polymorphic form thereof.

Abstract: A fuel cell device includes at least one fuel cell column containing first and second fuel cell stacks, a fuel manifold located between the first and second fuel cell stacks and configured to provide fuel to the first and second fuel cell stacks, and a dielectric material located to electrically isolate the first and second fuel cell stacks from the fuel manifold.

Abstract: The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.

Abstract: The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.

Abstract: The present invention relates to quinolin-2(1H)-one derivatives polymorph and its process thereof. Formula (I).

Abstract: The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.

Abstract: The present invention relates to quinolin-2(1H)-one derivatives polymorph and its process thereof. Formula (I).

Abstract: Sodium Bi-carbonate, more commonly known as Baking Soda, is a chemical often used in killing odor or foul smell emanating from food kept in refrigerators and cooling cabinets and also as a preservative to extend the shelf life of food items. Invention titled “Active Scrub with Baking Soda for Fridge Freshening and Food Preservation” exploits these applications. This invention comprises—a process to scrub the environmental air contained inside the cooling chamber of refrigerators, freezers and cooling cabinets etc; with Baking Soda, using air ballast of the cold air circulation system of respective equipment; and—an attachment to accomplish this process. Such scrubbing facilitates chemical reaction of baking soda with the acidic contents of environmental air and the resultant change in pH in turn helps in killing the odor and extending the shelf-life of contents/food items stored there-in.

Abstract: A parallel stacked symmetrical and differential inductor and manufacturing method of the same is disclosed. The parallel stacked symmetrical and differential inductor is disposed on a substrate and comprises at least one first conductive layer (202, 204) disposed on an insulating layer and at least one subsequent conductive layer (206, 208) disposed on a plurality of insulating layers stacked under the at least one first conductive layer (202, 204). The at least one first conductive layer (202, 204) and each of the at least one subsequent conductive layer (206, 208) are electrically connected by a first plurality of conductive plugs (214) in a winding region (104). Each of the at least one subsequent conductive layer (206, 208) are electrically connected by a second plurality of conductive plugs (212) in a bridge region (102).

Abstract: A novel heterocyclic compound belonging to ‘triazine-aryl-bis-indoles’, useful for the treatment of asthma. The pathway by which this compound inhibits asthma is also demonstrated. The present invention also provides a process for the preparation of above compounds and their derivatives are presented.